As a result of vaccination or infection, our immune system produces antibodies that attach to the spike protein of SARS-CoV-2, preventing the virus from entering and replicating within cells.
NorthSea Therapeutics bags FDA rare paediatric disease tag for NASH drug – Pharmaceutical Technology
The company has said that its novel drug SEFA-6179 was well tolerated in Phase I trials. Credit: Shutterstock / Studio Romantic Dutch biotech firm, NorthSea